This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Janssen Pharmaceutica Nv, Pharmacyclics, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,101 
1 out of 194 
Years Active: 2017
Title: The Innovations of Leo Cheung
Introduction
Leo Cheung is an accomplished inventor based in Fremont, CA. He has made significant contributions to the field of biotechnology, particularly in the treatment of B-cell malignancies. His innovative work has led to the development of a patent that addresses critical medical challenges.
Latest Patents
Leo Cheung holds a patent for "Bruton's tyrosine kinase inhibitor combinations and uses thereof." This patent discloses methods, compositions, and kits for treating B-cell malignancies by administering a combination of a BTK inhibitor, such as ibrutinib, and a PIM inhibitor. Additionally, it outlines approaches for treating BTK-resistant B-cell malignancies using similar combinations.
Career Highlights
Throughout his career, Leo has worked with notable companies in the pharmaceutical industry, including Pharmacyclics, Inc. and Janssen Pharmaceutica NV. His experience in these organizations has allowed him to contribute to groundbreaking research and development in cancer treatment.
Collaborations
Leo has collaborated with esteemed colleagues, including Hsu-Ping Kuo and Hsin-Kang Hsieh. These partnerships have further enhanced his research and innovation in the field.
Conclusion
Leo Cheung's contributions to biotechnology and his innovative patent for treating B-cell malignancies highlight his role as a significant inventor in the medical field. His work continues to impact the lives of many patients facing challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile